Recap: Paratek Pharmaceuticals Q3 Earnings

Paratek Pharmaceuticals (NASDAQ:PRTK) reported its Q3 earnings results on Monday, November 8, 2021 at 04:05 PM.

Here's what investors need to know about the announcement.

Paratek Pharmaceuticals their estimated earnings by 17.78%, reporting an EPS of $-0.37 versus an estimate of $-0.45, which surprised analysts.

Revenue was up $10,788,000 from the same period last year.

Last quarter the company missed on EPS by $0.11, which was followed by a 4.14% drop in the share price the next day.

Here's a look at Paratek Pharmaceuticals's past performance:

Quarter	Q2 2021	Q1 2021	Q4 2020	Q3 2020
EPS Estimate	0.31	-0.38	-0.04	-0.61
EPS Actual	0.20	-0.39	-0.49	-0.46
Revenue Estimate	60.99M	28.72M	34.04M	11.90M
Revenue Actual	57.49M	16.43M	16.02M	13.66M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.